Genetic analysis of Down syndrome facilitated by mouse chromosome engineering

Bioengineered Bugs

Volumn 3, Issue 1, 2012, Pages 8-12

  Zhang, Li ^a,b   Fu, Dawei ^a   Belichenko, Pavel V ^d   Liu, Chunhong ^a   Kleschevnikov, Alexander M ^d   Pao, Annie ^a   Liang, Ping ^e   Clapcote, Steven J ^f   Mobley, William C ^d   Yu, Y Eugene ^a,c  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^c UNIVERSITY AT BUFFALO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BROCK UNIVERSITY   (Canada)

^f UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Chromosome engineering; Down syndrome; Genetic dissection; Mouse models; Trisomy 21

Indexed keywords

ARTICLE; CHROMOSOME DUPLICATION; CHROMOSOME MUTATION; DOWN SYNDROME; GENETIC ANALYSIS; MOUSE; NONHUMAN; TRISOMY 21;

ANIMALS; CHROMOSOMES; CHROMOSOMES, HUMAN, PAIR 21; DOWN SYNDROME; GENETIC ENGINEERING; HUMANS; MICE;

EID: 84863289832     PISSN: 19491018     EISSN: 19491026     Source Type: Journal    
DOI: 10.4161/bbug.3.1.17696     Document Type: Article

References (40)

1. Epstein CJ. The consequences of chromosome imbalance. Am J Med Genet Suppl 1990; 7:31-37; PMID: 2149968
2. Korbel JO, Tirosh-Wagner T, Urban AE, Chen XN, Kasowski M, Dai L, et al. The genetic architecture of Down syndrome phenotypes revealed by highresolution analysis of human segmental trisomies. Proc Natl Acad Sci USA 2009; 106:12031-12036; PMID:19597142; http://dx.doi.org/10.1073/pnas.0813248106
3. Korenberg JR, Chen XN, Schipper R, Sun Z, Gonsky R, Gerwehr S, et al. Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc Natl Acad Sci USA 1994; 91:4997-5001; PMID:8197171; http://dx.doi.org/10.1073/pnas.91.11.4997
4. Lyle R, Bena F, Gagos S, Gehrig C, Lopez G, Schinzel A, et al. Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21. Eur J Hum Genet 2009; 17:454-466; PMID:19002211; http://dx.doi.org/10.1038/ejhg.2008.214
5. Sinet PM, Theophile D, Rahmani Z, Chettouh Z, Blouin JL, Prieur M, et al. Mapping of the Down syndrome phenotype on chromosome 21 at the molecular level. Biomed Pharmacother 1994; 48:247-252; PMID:7999986; http://dx.doi.org/10.1016/0753-3322(94)90140-6
6. Reeves RH, Irving NG, Moran TH, Wohn A, Kitt C, Sisodia SS, et al. A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet 1995; 11:177-184; PMID:7550346; http://dx.doi.org/10.1038/ng1095-177
7. Sago H, Carlson EJ, Smith DJ, Kilbridge J, Rubin EM, Mobley WC, et al. Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proc Natl Acad Sci USA 1998; 95:6256-6261; PMID:9600952; http://dx.doi.org/10.1073/pnas.95.11.6256
8. Olson LE, Richtsmeier JT, Leszl J, Reeves RH. A chromosome 21 critical region does not cause specific Down syndrome phenotypes. Science 2004; 306:687-690; PMID:15499018; http://dx.doi.org/10.1126/science.1098992
9. Li Z, Yu T, Morishima M, Pao A, LaDuca J, Conroy J, et al. Duplication of the entire 22.9-Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities. Hum Mol Genet 2007; 16:1359-1366; PMID: 17412756; http://dx.doi.org/10.1093/hmg/ddm086
10. Pereira PL, Magnol L, Sahun I, Brault V, Duchon A, Prandini P, et al. A new mouse model for the trisomy of the Abcg1-U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome. Hum Mol Genet 2009; 18:4756-4769; PMID:19783846; http://dx.doi.org/10.1093/hmg/ddp438
11. Yu T, Li Z, Jia Z, Clapcote SJ, Liu C, Li S, et al. A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions. Hum Mol Genet 2010; 19:2780-2791; PMID:20442137; http://dx.doi.org/10.1093/hmg/ddq179
12. Liu C, Morishima M, Yu T, Matsui SI, Zhang L, Fu D, et al. Genetic analysis of Down syndromeassociated heart defects in mice. Hum Genet 2011; http://dx.doi.org/http://dx.doi.org/10.1007/s00439-011-0980-2
13. O'Doherty A, Ruf S, Mulligan C, Hildreth V, Errington ML, Cooke S, et al. An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes. Science 2005; 309:2033-2037; PMID:16179473; http://dx.doi.org/10.1126/science.1114535
14. Shinohara T, Tomizuka K, Miyabara S, Takehara S, Kazuki Y, Inoue J, et al. Mice containing a human chromosome 21 model behavioral impairment and cardiac anomalies of Down's syndrome. Hum Mol Genet 2001; 10:1163-1175; PMID:11371509; http://dx.doi.org/10.1093/hmg/10.11.1163
15. Torfs CP, Christianson RE. Anomalies in Down syndrome individuals in a large population-based registry. Am J Med Genet 1998; 77:431-438; PMID: 9632176; http://dx.doi.org/10.1002/(SICI)1096-8628(19980605)77:5,431::AID-AJMG15.3.0.CO;2-J
16. Moore CS. Postnatal lethality and cardiac anomalies in the Ts65Dn Down syndrome mouse model. Mamm Genome 2006; 17:1005-1012; PMID:17019652; http://dx.doi.org/10.1007/s00335-006-0032-8
17. Dunlevy L, Bennett M, Slender A, Lana-Elola E, Tybulewicz VL, Fisher EM, et al. Down syndrome-like cardiac developmental defects in embryos of the transchromosomic Tc1 mouse. Cardiovasc Res 2010; 88:287-295; PMID:20558441; http://dx.doi.org/10.1093/cvr/cvq193
18. Athale UH, Razzouk BI, Raimondi SC, Tong X, Behm FG, Head DR, et al. Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience. Blood 2001; 97:3727-3732; PMID:11389009; http://dx.doi.org/10.1182/blood.V97.12.3727
19. Wechsler J, Greene M, McDevitt MA, Anastasi J, Karp JE, Le Beau MM, et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet 2002; 32:148-152; PMID:12172547; http://dx.doi.org/10.1038/ng955
20. Li Z, Godinho FJ, Klusmann JH, Garriga-Canut M, Yu C, Orkin SH. Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1. Nat Genet 2005; 37:613-619; PMID:15895080; http://dx.doi.org/10.1038/ng1566
21. Kirsammer G, Jilani S, Liu H, Davis E, Gurbuxani S, Le Beau MM, et al. Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome. Blood 2008; 111:767-775; PMID: 17901249; http://dx.doi.org/10.1182/blood-2007-04-085670
22. Alford KA, Slender A, Vanes L, Li Z, Fisher EM, Nizetic D, et al. Perturbed hematopoiesis in the Tc1 mouse model of Down syndrome. Blood 2010; 115:2928-2937; PMID:20154221; http://dx.doi.org/10.1182/blood-2009-06-227629
23. Ng AP, Hyland CD, Metcalf D, Carmichael CL, Loughran SJ, Di Rago L, et al. Trisomy of Erg is required for myeloproliferation in a mouse model of Down syndrome. Blood 2010; 115:3966-3969; PMID:20007548; http://dx.doi.org/10.1182/blood-2009-09-242107
24. Carmichael CL, Majewski IJ, Alexander WS, Metcalf D, Hilton DJ, Hewitt CA, et al. Hematopoietic defects in the Ts1Cje mouse model of Down syndrome. Blood 2009; 113:1929-1937; PMID:19109561; http://dx.doi.org/10.1182/blood-2008-06-161422
25. Belichenko NP, Belichenko PV, Kleschevnikov AM, Salehi A, Reeves RH, Mobley WC. The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome. J Neurosci 2009; 29:5938-5948; PMID:19420260; http://dx.doi.org/10.1523/JNEUROSCI.1547-09.2009
26. Ahn KJ, Jeong HK, Choi HS, Ryoo SR, Kim YJ, Goo JS, et al. DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects. Neurobiol Dis 2006; 22:463-472; PMID:16455265; http://dx.doi.org/10.1016/j.nbd.2005.12.006
27. Cramer NP, Best TK, Stoffel M, Siarey RJ, Galdzicki Z. GABAB-GIRK2-mediated signaling in Down syndrome. Adv Pharmacol 2010; 58:397-426; PMID:20655490; http://dx.doi.org/10.1016/S1054-3589(10)58015-3
28. Yu T, Liu C, Belichenko P, Clapcote SJ, Li S, Pao A, et al. Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice. Brain Res 2010; 1366:162-171; PMID:20932954; http://dx.doi.org/10.1016/j.brainres.2010.09.107
29. Chakrabarti L, Best TK, Cramer NP, Carney RS, Isaac JT, Galdzicki Z, et al. Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome. Nat Neurosci 2010; 13:927-934; PMID:20639873; http://dx.doi.org/10.1038/nn.2600
30. Chakrabarti L, Galdzicki Z, Haydar TF. Defects in embryonic neurogenesis and initial synapse formation in the forebrain of the Ts65Dn mouse model of Down syndrome. J Neurosci 2007; 27:11483-11495; PMID: 17959791; http://dx.doi.org/10.1523/JNEUROSCI.3406-07.2007
31. Wisniewski KE, Wisniewski HM, Wen GY. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 1985; 17:278-282; PMID:3158266; http://dx.doi.org/10.1002/ana.410170310
32. Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 1981; 10:122-126; PMID:7283399; http://dx.doi.org/10.1002/ana.410100203
33. Mann DM. The neuropathology of Alzheimer's disease: a review with pathogenetic, aetiological and therapeutic considerations. Mech Ageing Dev 1985; 31:213-255; PMID:3906293; http://dx.doi.org/10.1016/0047-6374(85)90092-2
34. Baxter MG, Chiba AA. Cognitive functions of the basal forebrain. Curr Opin Neurobiol 1999; 9:178-183; PMID:10322180; http://dx.doi.org/10.1016/S0959-4388(99)80024-5
35. Holtzman DM, Santucci D, Kilbridge J, Chua-Couzens J, Fontana DJ, Daniels SE, et al. Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc Natl Acad Sci USA 1996; 93:13333-13338; PMID:8917591; http://dx.doi.org/10.1073/pnas.93.23.13333
36. Cooper JD, Salehi A, Delcroix JD, Howe CL, Belichenko PV, Chua-Couzens J, et al. Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion. Proc Natl Acad Sci USA 2001; 98:10439-10444; PMID:11504920; http://dx.doi.org/10.1073/pnas.181219298
37. Salehi A, Delcroix JD, Belichenko PV, Zhan K, Wu C, Valletta JS, et al. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron 2006; 51:29-42; PMID:16815330; http://dx.doi.org/10.1016/j.neuron.2006.05.022
38. Granholm AC, Sanders L, Seo H, Lin L, Ford K, Isacson O. Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndrome. Hippocampus 2003; 13: 905-914; PMID:14750653; http://dx.doi.org/10.1002/hipo.10130
39. Wallace HA, Marques-Kranc F, Richardson M, Luna-Crespo F, Sharpe JA, Hughes J, et al. Manipulating the mouse genome to engineer precise functional syntenic replacements with human sequence. Cell 2007; 128:197-209; PMID:17218265; http://dx.doi.org/10.1016/j.cell.2006.11.044
40. Kazuki Y, Schulz TC, Shinohara T, Kadota M, Nishigaki R, Inoue T, et al. A new mouse model for Down syndrome. J Neural Transm Suppl 2003; 67:1-20; PMID:1506823512